BCL2L1 and acute lymphoblastic leukemia: Bcl-xL is expressed in a subset of leukemia/lymphoma cells (AML, ALL, Hodgkin’s lymphoma, Burkitt’s lymphoma, DLBCL, FL, MZL, MM) and confers them resistant to chemotherapy [83].